Why One Woman Prefers the Term ‘Cancer Alumni’ After Treatment for Lymphoma

Video

The term “survivor” is often used to describe people who have successfully completed their cancer treatments, but Sonia Su feels like it doesn’t quite capture the complexity of what it means to be in remission.

As a three-time “cancer alumni,” as she prefers to be called, Sonia Su recognizes the unforgiving nature of cancer.

In an interview with CURE®, Su, who was diagnosed with primary mediastinal large B-cell lymphoma, shared her perspective on why she feels that the term “survivor” does not offer a complete understanding of what it means to be in remission from cancer. She pointed out that receiving a cancer diagnosis will impact the rest of someone’s life, even after successfully completing treatment.

“We, as cancer survivors, essentially all took the ‘courses’ of cancer and graduated, and to use the word ‘survived’ essentially means that we’ll be okay from now on,” Su said. “And to be honest, we never know. The harsh reality is that cancer can come back at any point.”

Transcription

So, I don't think I really realized the potentially negative connotation of the word ‘survivor’ until I had actually presented this nonprofit idea to one of my professors, and he used the word ‘alumni,’ like cancer alumni.

And I thought that that was such a such a great term to use, because it's true. He was a cancer survivor as well. We, as cancer survivors, essentially all took the ‘courses’ of cancer and graduated, and to use the word ‘survived’ essentially means that we'll be okay from now on. And to be honest, we never know. The harsh reality is that cancer can come back at any point. And I mean for me, especially, I'm only two years out, and medically, I think, you know, five years is like the safe zone. So, I don't even know if I can call myself a survivor. And if anything, I know I'm an alumni. I did go through all of that. And you know, that was a crazy learning experience, and I learned a lot.

But I think just recognizing that a lot of us also have a lot of fear of recurrence constantly, especially for people who have had relapses (is important). And so, I think it's just more about being slightly more considerate about the reality of cancer. We’ve survived it, but even as survivors or alumni, we’ll have long term effects and you know, our lives are forever changed. So, it's not that we can exactly go back to normal. It's just (that) we're always going to be living with the effects of cancer.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE